• Home
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • Services
    • Proteomics
    • Genomics Transcriptomics
    • Flow Cytometry
    • Assay Development
    • Monoclonal Antibodies
    • Biobanking
    • OLINK Services
    • Biomarker Data Analyses
  • R&D
  • Products
    • NEUROLINCS
    • FIMICS
    • BIOPRED
    • IVD Products
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
    • Your Customized Kit
  • Quality
  • Investors
    • Financial Management
    • Financial Data
    • Shareholders
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
  • Careers
Contact
Firalis
  • Home
  • About
  • Services
  • Products
  • R&D
  • Quality
  • Investors
  • Media

All Media

Reasons for hope on World Alzheimer’s Day

Reasons for hope on World Alzheimer’s Day

21st September : World Alzheimer's Day. 📅

21.09.2021

RNAs to predict COVID-19's cardiovascular outcomes

RNAs to predict COVID-19's cardiovascular outcomes

Check out the video presentation of COVIRNA Consortium

19.07.2021

Firalis, Laureat again for its High Potential

Firalis, Laureat again for its High Potential

Trophées Alsace Export 2020 - Prizewinner in category "Corporate with High Potential"

12.05.2021

Le test Covid-19 qui fait saliver le monde !

Parution de Firalis dans le magazine régional Point Eco Alsace.

10.03.2021

EASYCOV: INAUGURATION DE LA LIGNE DE PRODUCTION

EASYCOV: INAUGURATION DE LA LIGNE DE PRODUCTION

Firalis a inauguré la ligne de production automatisée, dédiée au production de "EasyCOV", le test rapide salivaire de dépistage du Covid-19 !

09.12.2020

HAS valide le remboursement d'EasyCOV*

HAS valide le remboursement d'EasyCOV*

*La Haute Autorité de Santé (HAS) valide l’utilisation et recommande le remboursement du test salivaire EasyCOV® sous conditions.

28.11.2020

TACKLING COVID-19: THE "COVIRNA" PROJECT

TACKLING COVID-19: THE "COVIRNA" PROJECT

A diagnostic test funded by the EU, to improve surveillance and care of COVID-19 patients

27.11.2020

Olink in Covid-19 R&D

Olink in Covid-19 R&D

Outstanding Olink technology offering for COVID-19 Research

06.08.2020

EasyCov: Covid-19 saliva test

EasyCov: Covid-19 saliva test

Firalis-produced and CE-marked "EasyCOV" saliva test, developed by Skillcell

18.06.2020

Firalis and EasyCOV on DNA

Firalis and EasyCOV on DNA

Firalis and the EasyCOV test are mentioned on an article published by the "DNA" (Les Dernières Nouvelles d'Alsace).

10.05.2020

Firalis against Covid-19 !

20.03.2020

Firalis on "Point Eco Alsace"

Biomarkers for Future's Medicines

13.03.2020

Theranostic Tool

13.03.2020

Firalis on « Les Echos »

13.03.2020

EU-funded (Eurostars) HeartLinc Program

EU-funded (Eurostars) HeartLinc Program

13.03.2020

Launch of the Biopred panel

13.03.2020

Load More

Contact Firalis

Firalis Group

© Copyright 2020 all rights reserved. 

The company logos, products and service marks are trademarks or registered trademarks of Firalis.

-----------------------------------------------------------------------------------------------------------------------

Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

-----------------------------------------------------------------------------------------------------------------------

Headquarter : 17 Rue du Fort 68330 Huningue FRANCE